共 50 条
- [5] Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials [J]. Rheumatology and Therapy, 2022, 9 : 1181 - 1191
- [7] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study [J]. Rheumatology and Therapy, 2023, 10 : 275 - 292